 SAN DIEGO, March 11, 2021 GLOBE NEWSWIRE -- Metacrine, Inc. Nasdaq: MTCR, a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced that management will host a conference call and webcast to discuss its fourth quarter and full year 2020 financial results and other business highlights on Thursday, March 18, 2021 at 8:30 a.m. ET. 